MedPath

Ethacrynic Acid

ETHACRYNIC ACID TABLETS, USP

Approved
Approval ID

f4e95ca1-502b-5305-e053-2995a90a5dc7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 17, 2023

Manufacturers
FDA

ST. MARY'S MEDICAL PARK PHARMACY

DUNS: 063050751

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ethacrynic Acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60760-773
Application NumberANDA211232
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ethacrynic Acid
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 17, 2023
FDA Product Classification

INGREDIENTS (6)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
ETHACRYNIC ACIDActive
Quantity: 25 mg in 1 1
Code: M5DP350VZV
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ethacrynic Acid - FDA Drug Approval Details